ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04744	Phototransduction	22/246	36/7206	5.25007529817e-24
ko05032	Morphine addiction	19/246	110/7206	4.07746051681e-09
ko04727	GABAergic synapse	17/246	110/7206	1.51032981581e-07
ko04724	Glutamatergic synapse	20/246	152/7206	1.84190260671e-07
ko04723	Retrograde endocannabinoid signaling	21/246	175/7206	4.39480440399e-07
ko05033	Nicotine addiction	11/246	56/7206	2.24214411664e-06
ko04725	Cholinergic synapse	18/246	160/7206	7.61295050593e-06
ko04721	Synaptic vesicle cycle	11/246	80/7206	7.64461170863e-05
ko04911	Insulin secretion	13/246	117/7206	0.000163307288774
ko04728	Dopaminergic synapse	16/246	185/7206	0.000554241544702
ko04144	Endocytosis	24/246	342/7206	0.000660243428538
ko04024	cAMP signaling pathway	20/246	279/7206	0.00188132308904
ko04713	Circadian entrainment	12/246	136/7206	0.00227824473874
ko04726	Serotonergic synapse	12/246	137/7206	0.00242307612154
ko00830	Retinol metabolism	6/246	42/7206	0.00278342806582
ko05030	Cocaine addiction	8/246	73/7206	0.00325281322911
ko05166	HTLV-I infection	2/246	292/7206	0.00445903063321
ko04742	Taste transduction	7/246	61/7206	0.00449199767125
ko04062	Chemokine signaling pathway	14/246	201/7206	0.00954368113507
ko05169	Epstein-Barr virus infection	1/246	206/7206	0.0104478580095
ko04080	Neuroactive ligand-receptor interaction	24/246	423/7206	0.0124888501255
ko04932	Non-alcoholic fatty liver disease (NAFLD)	1/246	182/7206	0.0218276046587
ko04060	Cytokine-cytokine receptor interaction	1/246	191/7206	0.0230319702627
ko00230	Purine metabolism	13/246	194/7206	0.0238969608568
ko04925	Aldosterone synthesis and secretion	8/246	105/7206	0.026693738488
ko05418	Fluid shear stress and atherosclerosis	1/246	173/7206	0.031662280044
ko05224	Breast cancer	1/246	174/7206	0.0318061028717
ko05034	Alcoholism	14/246	238/7206	0.0434229807203
ko05164	Influenza A	1/246	167/7206	0.0473234697848
ko04068	FoxO signaling pathway	1/246	167/7206	0.0473234697848